Reading between the (guide)lines-the KDIGO practice guideline on acute kidney injury in the individual patient

被引:105
作者
Okusa, Mark D. [1 ]
Davenport, Andrew [2 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Div Nephrol, Charlottesville, VA 22908 USA
[2] Royal Free Hosp, UCL Ctr Nephrol, London NW3 2QG, England
关键词
acute kidney injury; creatinine; KDIGO; RIFLE; ACUTE-RENAL-FAILURE; CONTRAST-INDUCED NEPHROPATHY; PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; INTENSIVE INSULIN THERAPY; CLINICAL GUIDELINES; 0.9-PERCENT SALINE; INHALED TOBRAMYCIN; N-ACETYLCYSTEINE; ISO-OSMOLAR;
D O I
10.1038/ki.2013.378
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The KDIGO guidelines for acute kidney injury (AKI) are designed to assist health-care providers around the world in managing patients with AKI. Clinical guidelines are intended to help the clinician make an informed decision based on review of the currently available evidence. Due to the generic nature of guidelines, it is sometimes difficult to translate a guideline for a particular individual patient who may have specific clinical circumstances. To illustrate this point, we have discussed the interpretation of the KDIGO guideline in patients who have subtleties in their clinical presentation, which may make treatment decisions less than straightforward.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 63 条
[1]   A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides [J].
Ali, MZ ;
Goetz, MB .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) :796-809
[2]  
[Anonymous], 1990, CLIN PRACTICE GUIDEL
[3]   Once daily aminoglycoside therapy - Is it less toxic than multiple daily doses and how should it be monitored? [J].
Barclay, ML ;
Kirkpatrick, CMJ ;
Begg, EJ .
CLINICAL PHARMACOKINETICS, 1999, 36 (02) :89-98
[4]   Preventing nephropathy induced by contrast medium [J].
Barrett, BJ ;
Parfrey, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) :379-386
[5]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[6]   The ethics of practice guidelines [J].
Berger, JT ;
Rosner, F .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (18) :2051-2056
[7]   Impact of Iso-Osmolar Versus Low-Osmolar Contrast Agents on Contrast-Induced Nephropathy and Tissue Reperfusion in Unselected Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (From the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial) [J].
Bolognese, Leonardo ;
Falsini, Giovanni ;
Schwenke, Carsten ;
Grotti, Simone ;
Limbruno, Ugo ;
Liistro, Francesco ;
Carrera, Arcangelo ;
Angioli, Paolo ;
Picchi, Andrea ;
Ducci, Kenneth ;
Pierli, Carlo .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (01) :67-74
[8]   Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study [J].
Brienza, Nicola ;
Giglio, Maria Teresa ;
Marucci, Massimo ;
Fiore, Tommaso .
CRITICAL CARE MEDICINE, 2009, 37 (06) :2079-2090
[9]   Acute renal failure associated with inhaled tobramycin [J].
Cannella, Carrie A. ;
Wilkinson, Samaneh T. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (19) :1858-1861
[10]   Oral Hydration and Alkalinization is Noninferior to Intravenous Therapy for Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease [J].
Cho, Roy ;
Javed, Nosheen ;
Traub, Darren ;
Kodali, Sobhan ;
Atem, Folefac ;
Srinivasan, Venkatraman .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2010, 23 (05) :460-466